Overall Technical outlook

Price Summary

The stock of GlaxoSmithKline Pharmaceuticals Limited experienced a -2.18% collapse, showcasing a lacklustre market performance.
On 2025-05-29, GlaxoSmithKline Pharmaceuticals Limited's stock opened at 3336.0, reached a high of 3374.9, dropped to a low of 3228.9, and closed lower -2.18% at 3263.4, with a trading volume of 244997 shares.
The top price for the stock in the last 52 weeks is 3348.2, with the bottom price being 1956.2.
The expected price range is between 2600.0 and 3500.0, with a mean anticipated price of 3072.0, according to 4 analysts.

Technicals


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
GLAXO aroon 892601
Aroon chart for GlaxoSmithKline Pharmaceuticals Limited


Bol. Bands: The asset's price remains above the upper Bollinger Band, reflecting strong bullish momentum since its last move. This could suggest that the asset is overbought, with traders possibly seeing this as a sign of continued strength. However, the extended position above the band could also be a warning of an impending correction or reversal, making it a critical point for decision-making.
GLAXO bbands 892601
Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited


Parabolic SAR: The PSAR continues to indicate a bullish outlook, setting a crucial support level. This strong support could bolster the ongoing upward trend, suggesting that the market may remain in a positive trajectory. Investors may view this as a sign of sustained bullish momentum.
GLAXO psar 892601
Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited


Stochastic: The stochastic indicator is in a bullish state, with the K-line crossing above both the D-line and the 80 mark. This alignment suggests strong upward momentum, implying that the market may continue its positive trajectory. Traders may see this as a sign of ongoing strength for GlaxoSmithKline Pharmaceuticals Limited.
GLAXO stoch 892601
Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages points to a bearish trend, but the slopes of the 20 and 50 SMAs are starting to waver. This weakening of the bearish momentum could indicate that the market is approaching a turning point, with the possibility of a bullish reversal on the horizon. Investors should be alert for signs of a trend change as the current downtrend may be losing steam.
GLAXO trippleSMA 892601
Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited


Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.